Soru

Zorluk: OrtaMedical History Evaluation

A 49-year-old woman is admitted to the hospital with a one-week history of progressively worsening fatigue, nausea without vomiting, and yellowing of her eyes. She notes her urine has become noticeably dark over the last three days. She denies abdominal pain, fever, or changes in stool color. Her past medical history is significant for type 2 diabetes mellitus, hyperlipidemia, and class II obesity. She had an uncomplicated laparoscopic cholecystectomy ten years ago. Her home medications include metformin and atorvastatin, both of which she has taken at stable doses for over five years. She does not use tobacco, alcohol, or illicit drugs. Vital signs are within normal limits. Physical examination demonstrates pronounced scleral icterus and generalized jaundice. Her abdomen is soft with mild right upper quadrant tenderness, but no hepatosplenomegaly or ascites is noted. Laboratory studies reveal the following:

AST: 1,650 U/L
ALT: 1,920 U/L
Alkaline phosphatase: 125 U/L
Total bilirubin: 6.8 mg/dL
Direct bilirubin: 4.5 mg/dL
INR: 1.2

Viral hepatitis serologies (A, B, C, and E) and antinuclear antibodies are negative. A right upper quadrant ultrasound demonstrates normal intrahepatic and extrahepatic bile ducts with an absent gallbladder. Which of the following previously unelicited elements of the patient's history is the most likely cause of her clinical presentation?

  1. Recent initiation of a botanical extract for weight managementCevap
  2. B
    Completion of a short course of amoxicillin-clavulanate three weeks ago
  3. C
    Inadvertent doubling of her prescribed atorvastatin dosage
  4. D
    Daily consumption of large quantities of grapefruit juice
  5. E
    Recent transition to a high-protein, ketogenic dietary regimen

Cevap

Recent initiation of a botanical extract for weight management
This patient presents with acute, severe hepatocellular injury (AST and ALT > 1,000 U/L) in the absence of viral, autoimmune, or biliary etiologies. Drug-induced liver injury (DILI) is the most likely diagnosis. Over-the-counter botanical and dietary supplements, particularly those marketed for weight loss (such as green tea extract, usnic acid, and garcinia cambogia), are well-documented and common causes of acute, severe hepatocellular necrosis. Patients frequently omit these supplements from their medical history, assuming they are safe or irrelevant because they are 'natural.' Therefore, active and targeted querying of botanical dietary supplement use is the most critical missing historical element to explain this clinical presentation.

Adım Adım Çözüm

1
Analyze the laboratory pattern
The patient exhibits a purely hepatocellular pattern of injury, characterized by massive elevations in AST and ALT (> 1,000 U/L) with normal alkaline phosphatase.
Differentiating hepatocellular from cholestatic injury narrows the differential diagnosis for hepatic dysfunction.
2
Evaluate and rule out primary etiologies
Acute viral hepatitis (serologies negative), autoimmune hepatitis (ANA negative), and extrahepatic biliary obstruction (ultrasound normal) are systematically ruled out.
Excluding infectious, autoimmune, and anatomic causes isolates the etiology to a toxic or metabolic exposure.
3
Review the established medication history
The patient has been on stable, long-term therapy with metformin and atorvastatin. Acute massive liver injury is not a classic manifestation of these medications, especially after years of tolerance.
Chronic stable medications are rarely the culprit for sudden fulminant hepatic failure without a recent dose change or new interacting agent.
4
Identify the missing historical element
Drug-induced liver injury (DILI) from non-prescription, over-the-counter dietary or botanical supplements must be highly suspected.
Patients frequently omit supplements from their medical history unless specifically queried, and products marketed for weight loss are well-documented causes of acute hepatocellular necrosis.

Anahtar Kavram

Active interrogation regarding the use of over-the-counter botanical and dietary supplements is a critical component of medical history evaluation in patients presenting with unexplained acute hepatocellular injury.
Tahmini Süre:1m 30s
Bu soruyu puanla